Effects of the treatment with proxazole citrate on the utero-placental blood flow of patients affected by EPH-gestosis.
D001593:Benzyl Compounds / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects; D004487:Edema / Q000188:drug therapy; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D010069:Oxadiazoles / Q000627:therapeutic use*; D010920:Placenta / Q000098:blood supply*; D011225:Pre-Eclampsia / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011507:Proteinuria / Q000188:drug therapy; D014599:Uterus / Q000098:blood supply*
D001593:Benzyl Compounds; D010069:Oxadiazoles